Sex differences in all-cause and cardiovascular mortality, hospitalization for individuals with and without diabetes, and patients with diabetes diagnosed early and late

Diabetes Care

Volumn 36, Issue 9, 2013, Pages 2582-2590

  Roche, Madonna M ^a   Wang, Peizhong Peter ^b  

^a Newfoundland and Labrador Centre for Health Information   (Canada)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; CANADA; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; EARLY DIAGNOSIS; FEMALE; GENDER; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; SEX DIFFERENCE;

AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; DIABETES MELLITUS, TYPE 2; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 84890435169     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1272     Document Type: Article

References (39)

1. International Diabetes Federation. The Diabetes Atlas. 5thed. Brussels, International Diabetes Federation, 2011
2. Public Health Agency of Canada. Diabetes in Canada: Facts and figures from a public health perspective. Ottawa, Canada, Health Canada, 2011
3. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 1992;15: 815-819
4. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 2003;46: 3-19
5. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20: 537-544
6. Tuomilehto J, Lindström J, Eriksson JG, et al Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344: 1343-1350
7. Knowler WC, Barrett-Connor E, Fowler SE, et al Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346: 393-403
8. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose controlwith sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352: 837-853
9. Booth GL, Kapral MK, Fung K, Tu JV. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 2006;368: 29-36
10. Jeerakathil T, Johnson JA, Simpson SH, Majumdar SR. Short-term risk for stroke is doubled in persons with newly treated type 2 diabetes compared with persons without diabetes: a population-based cohort study. Stroke 2007;38: 1739-1743
11. Preis SR, Hwang SJ, Coady S, et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation 2009;119: 1728-1735
12. Barnett KN, Ogston SA, McMurdo MET, Morris AD, Evans JMM. A 12-year followup study of all-cause and cardiovascular mortality among 10, 532 people newly diagnosed with Type 2 diabetes in Tayside, Scotland. Diabet Med 2010;27: 1124-1129
13. Howard BV, Cowan LD, Go O, Welty TK, Robbins DC, Lee ET. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study. Diabetes Care 1998;21: 1258-1265
14. Becker A, Bos G, de Vegt F, et al. Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease. 10- year follow-up of the Hoorn Study. Eur Heart J 2003;24: 1406-1413
15. Natarajan S, Liao Y, Cao G, Lipsitz SR, McGee DL. Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease. Arch Intern Med 2003;163: 1735-1740
16. Juutilainen A, Kortelainen S, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 2004;27: 2898-2904
17. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006;332: 73-78
18. Orchard TJ. The impact of gender and general risk factors on the occurrence of atherosclerotic vascular disease in noninsulin- dependent diabetes mellitus. Ann Med 1996;28: 323-333
19. Lee WL, Cheung AM, Cape D, Zinman B. Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care 2000; 23: 962-968
20. Kanaya AM, Grady D, Barrett-Connor E. Explaining the sex difference in coronary heart diseasemortality among patients with type 2 diabetes mellitus: a metaanalysis. Arch InternMed 2002;162: 1737-1745
21. Statistics Canada. Table 102-0552.Deaths and mortality rate, by selected grouped causes and sex, Canada, provinces and territories, annual, CANSIM (database). Available fromhttp://www5.statcan.gc.ca/ cansim/a01?lang=eng. Accessed 11 March 2011
22. Canadian Institute for Health Information. Health Indicators 2012. Ottawa, Canada, Canadian Institute for Health Information, 2012
23. Hux JE, Ivis F, Flintoft V, Bica A. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002; 25: 512-516
24. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40: 373-383
25. Kleinbaum DG, Klein M. Survival Analysis: A Self-Learning Text. 3rd ed. New York, Springer, 2011
26. Logue J, Walker JJ, Colhoun HM, et al Scottish Diabetes Research Network Epidemiology Group. Domen develop type 2 diabetes at lower body mass indices than women? Diabetologia 2011;54: 3003-3006
27. Homko CJ, Zamora L, Santamore WP, Kashem A, McConnell T, Bove AA. Gender differences in cardiovascular risk factors and risk perception among individuals with diabetes. Diabetes Educ 2010;36: 483-488
28. Hu FB, Stampfer MJ, Haffner SM, Solomon CG, Willett WC, Manson JE. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 2002;25: 1129-1134
29. Wexler DJ, Grant RW, Meigs JB, Nathan DM, Cagliero E. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 2005; 28: 514-520
30. Gouni-Berthold I, Berthold HK, Mantzoros CS, Böhm M, Krone W. Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes.Diabetes Care 2008;31: 1389-1391
31. Statistics Canada. Canadian Community Health Survey (CCHS), share file. Statistics Canada, 2009/2010
32. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 1991;265: 627-631
33. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352: 854-865
34. Patel A, MacMahon S, Chalmers J, et al ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358: 2560-2572
35. Duckworth W, Abraira C, Moritz T, et al VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360: 129-139
36. Gerstein HC, Miller ME, Byington RP, et al Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. NEngl JMed 2008;358: 2545-2559
37. Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ 2011;343:d4169
38. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. NEngl JMed 2008;359: 1577-1589
39. Dailey G. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes. Clin Ther 2011;33: 665-678